Evidence map›Paper›PMID 42719565›Full record

ReviewFrontiers in endocrinology2026

Sex-specific differences in pancreatic α-cell function.

Emmanuel Ampofo, Selina Wrublewsky, Matthias W Laschke

Abstract readReview
In one paragraph

Review in Frontiers in endocrinology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Emmanuel AmpofoInstitute for Clinical and Experimental Surgery, PharmaScienceHub (PSH), Saarland University, Homburg, Germany.
Selina WrublewskyInstitute for Clinical and Experimental Surgery, PharmaScienceHub (PSH), Saarland University, Homburg, Germany.
Matthias W LaschkeInstitute for Clinical and Experimental Surgery, PharmaScienceHub (PSH), Saarland University, Homburg, Germany.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Although sex is a critical biological variable determining physiology, disease risk and therapeutic responses, it remains underrepresented in biomedical research. While sex-dependent differences are well established in cardiovascular and metabolic diseases, their impact on glucagon biology is less understood. Glucagon is the key counter-regulatory hormone to insulin and plays a central role in glucose homeostasis by regulating hepatic glucose production. To date, only a limited number of studies have addressed sex-specific differences in glucagon plasma levels, secretion and α-cell function, indicating that females tend to exhibit a higher glucagon secretion. For the first time, this review summarizes the current literature on glucagon biology suggesting a sex-biased regulation of α-cell activity.

Indexed as

GlucagonGlucagon-Secreting CellsSex CharacteristicsAnimalsFemaleHumansInsulinMaleGlucagonInsulinglucagonislets of langerhanspancreassexα-cells

Identifiers

PMID42719565
PMCPMC13554837

What Socratic holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.